Table 1.
SET7/9 Target Protein | Methylation Sites | Effect of the Modification | Reference |
---|---|---|---|
Histone H1 | K12, K14, K17, K20, K21, K27, K111 |
Modulation of the affinity of histone H1 to chromatin during human pluripotent cells differentiation | [31] |
Histone H1.4 | K34, K127, K129, K130 | Prevention of acetylation at the same sites, heterochromatin formation | [31] |
Histone H2.A | K5, K13, K15 | Unknown | [3] |
Histone H2.B | K15 | Unknown | [3] |
Histone H3 | K4 | Activation of transcription | [1] |
Suv39H1 | K25, K123 | Heterohromatin relaxation, genome instability | [32] |
DNMT1 | K142 | Promotion of DNMT1 ubiquitination and proteasomal degradation | [33] |
K1094 | Decrease of the DNMT1 level | [34] | |
TAF7 | K5 | Enhancement of TAF7 activity as co-factor of RNA polymerase II | [8] |
TAF10 | K189 | Enhancement of TAF10 activity as co-factor of RNA polymerase II, activation of transcription of TAF10 target genes | [35] |
YAP1 | K494 | Retention of YAP1 in the cytoplasm | [17] |
β-catenin | K180 | Promotion of β-catenin ubiquitination by (GSK)-3b and its subsequent proteasomal degradation | [36] |
STAT3 | K140 | Dissociation of STAT3 from promoter elements, downregulation of STAT3-dependent genes expression | [37] |
E2F1 | K185 | Promotion of E2F1 ubiquitination and subsequent proteasomal degradation | [38] |
Unknown | Enhancement of E2F transactivation of its target genes | [39] | |
pRb | K873 | Enhancement of pRB-dependent repression of transcription | [40] |
K810 | Promotion of p65/RelA ubiquitination and its subsequent proteasomal degradation | [41] | |
YY1 | K173, K411 | Retention of YY1 in the cytoplasm | [42] |
p65/RelA | K37 | Translocation to the nucleus and transactivation of target genes | [43] |
K314, K315 | Promotion of p65/RelA ubiquitination and subsequent proteasomal degradation | [44] | |
FOXO3 | K270 | Downregulation of FOXO3-dependent transactivation of BIM | [45] |
K271 | Increase of the FOXO3 transactivation potential | [46] | |
Hif1α | K32 | Suppression of Hif1α transactivation of its target genes | [47,48] |
p53 | K372 | Stabilization, translocation to the nucleus and transactivation of target genes | [7] |
SIRT1 | K233, K235, K236, K238 | Enhancement of SIRT1-dependent p53 acetylation and activation | [49] |